APA (7th ed.) Citation

SH, B., GE, H., SMH, Y., FP, B., SJL, B., WH, v. G., . . . MH, d. B. (2022). Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study. Journal of the American Heart Association, 11(15), e024952. https://doi.org/10.1161/JAHA.121.024952

Chicago Style (17th ed.) Citation

SH, Binnenmars, et al. "Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study." Journal of the American Heart Association 11, no. 15 (2022): e024952. https://doi.org/10.1161/JAHA.121.024952.

MLA (9th ed.) Citation

SH, Binnenmars, et al. "Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study." Journal of the American Heart Association, vol. 11, no. 15, 2022, p. e024952, https://doi.org/10.1161/JAHA.121.024952.